Carboxyfullerene nanoparticles alleviate acute hepatic injury in severe hemorrhagic shock.

Chen, Gan; Song, Xiang; Wang, Bo; You, Guoxing; Zhao, Jingxiang; Xia, Sha; Zhang, Yuhua; Zhao, Lian et al. · Biomaterials · 2017

basic_science · Level V

Where this comes from

Abstract

Hemorrhagic shock/resuscitation involves overwhelming reactive oxygen species (ROS) that cause oxidative stress, inflammation, and subsequent tissue injury. We investigated the effects of the potent antioxidant carboxyfullerene (C<sub>3</sub>) on acute liver injury during hemorrhage shock/resuscitation. C<sub>3</sub> infusion reduced the alanine aminotransferase (ALT) activity, methemoglobin content, malondialdehyde content, myeloperoxidase activity and expression levels of tumor necrosis factor -α and interleukin-6; it increased superoxide dismutase activity in the liver. The histologic injury score and apoptotic index were also markedly decreased after C<sub>3</sub> treatment compared with the vehicle group. Additionally, C<sub>3</sub>-treated rats showed a significant decrease in nuclear factor-κB DNA binding capacity, which was preceded by reduced phosphorylation of the nuclear factor κB (NF-κB) p65 subunit in the liver. C<sub>3</sub> nanoparticles ameliorate oxidative stress, the inflammatory response, and subsequent acute liver injury after hemorrhagic shock/resuscitation. These protective effects appear to be mediated through the inhibition of the nuclear factor-κB pathway. C<sub>3</sub> treatment may be a promising strategy to improve tissue injury in hemorrhagic shock/resuscitation.

Medical subject headings